Vertex Pharmaceutic (VRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | VRTX | BMY | AMGN | GILD | ILMN |
Company | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
Price Information | |||||
Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
Open | 420.30 | 53.00 | 284.22 | 72.92 | 135.51 |
High | 420.42 | 53.69 | 286.82 | 73.06 | 138.68 |
Low | 412.65 | 52.85 | 282.55 | 72.55 | 134.47 |
Last | 417.32 | 53.25 | 286.30 | 73.01 | 138.68 |
Change | -1.14 | +0.70 | +4.53 | +0.60 | +4.88 |
% Change | -0.27% | +1.33% | +1.61% | +0.83% | +3.65% |
Volume | 905,400 | 13,077,600 | 2,256,300 | 7,747,500 | 951,600 |
20-Day Average Volume | 1,045,085 | 20,769,045 | 3,134,110 | 7,477,905 | 1,626,670 |
Previous Close | 418.46 | 52.55 | 281.77 | 72.41 | 133.80 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 415.37 | 52.40 | 275.97 | 73.48 | 134.87 |
20-Day Raw Stochastic | 38.30% | 62.50% | 97.21% | 25.41% | 63.47% |
20-Day Relative Strength | 50.28% | 59.38% | 53.75% | 43.89% | 53.13% |
Weighted Alpha | +30.80 | -19.90 | +18.50 | -12.50 | -33.70 |
Today's Opinion | 56% Buy | 8% Buy | 40% Buy | 88% Sell | 8% Buy |
Previous Opinion | 56% Buy | 8% Sell | 24% Buy | 88% Sell | 24% Sell |
Last Month's Opinion | 100% Buy | 56% Sell | 40% Buy | 40% Sell | 8% Buy |
Performance | |||||
5-Days | |||||
%Chg | +1.26% since 03/20/24 | +2.64% since 03/20/24 | +4.85% since 03/20/24 | -1.31% since 03/20/24 | +4.12% since 03/20/24 |
Low | 412.19 on 03/22/24 | 51.52 on 03/22/24 | 274.39 on 03/21/24 | 72.11 on 03/26/24 | 132.77 on 03/25/24 |
High | 420.42 on 03/27/24 | 53.69 on 03/27/24 | 286.82 on 03/27/24 | 74.28 on 03/21/24 | 144.19 on 03/21/24 |
1-Month | |||||
%Chg | -3.16% since 02/27/24 | +5.42% since 02/27/24 | +2.80% since 02/27/24 | -0.01% since 02/27/24 | -0.77% since 02/27/24 |
Low | 406.97 on 03/15/24 | 50.28 on 02/29/24 | 268.17 on 03/15/24 | 71.92 on 02/29/24 | 125.82 on 03/18/24 |
High | 433.99 on 03/04/24 | 55.03 on 03/13/24 | 286.82 on 03/27/24 | 76.21 on 03/11/24 | 146.08 on 02/29/24 |
3-Month | |||||
%Chg | +2.27% since 12/27/23 | +3.98% since 12/27/23 | -0.08% since 12/27/23 | -9.16% since 12/27/23 | -2.70% since 12/27/23 |
Low | 403.43 on 01/02/24 | 47.58 on 02/06/24 | 268.17 on 03/15/24 | 71.37 on 02/16/24 | 125.82 on 03/18/24 |
High | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
6-Month | |||||
%Chg | +19.35% since 09/27/23 | -8.02% since 09/27/23 | +6.44% since 09/27/23 | -3.36% since 09/27/23 | +4.04% since 09/27/23 |
Low | 341.85 on 10/03/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 71.37 on 02/16/24 | 89.00 on 11/10/23 |
High | 448.40 on 01/30/24 | 58.46 on 09/29/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
Key Statistics | |||||
Market Capitalization, $K | 108,091,568 | 106,506,192 | 151,005,888 | 90,156,032 | 21,260,820 |
Shares Outstanding, K | 258,308 | 2,026,759 | 535,919 | 1,245,077 | 158,900 |
Annual Sales | 9,869,200,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
Annual Net Income | 3,619,600,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
Last Quarter Sales | 2,517,700,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 1,122,000,000 |
Last Quarter Net Income | 968,800,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | -176,000,000 |
60-Month Beta | 0.35 | 0.38 | 0.58 | 0.18 | 1.19 |
Per-Share Information | |||||
Most Recent Earnings | 4.20 on 02/05/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
Latest Earnings Date | 05/06/24 | 04/25/24 | 04/25/24 | 04/25/24 | 04/23/24 |
Most Recent Dividend | N/A | 0.600 on 01/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
Ratios | |||||
Price/Earnings ttm | 30.95 | 6.97 | 15.06 | 10.80 | 154.09 |